Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine
Authors:
- M Murrieta-AguttesMMM Murrieta-Aguttes
- 1 July 2000
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 85 (1) , 64-69
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adhesion molecules and H1‐antihistaminesClinical & Experimental Allergy, 1997
- Reduction of soluble ICAM‐1 levels in nasal secretion by H1‐blockers in seasonal allergic rhinitisAllergy, 1997
- Pharmacokinetic Analysis of Mizolastine in Healthy Young Volunteers After Single Oral and Intravenous Doses: Noncompartmental Approach and Compartmental ModelingJournal of Pharmacokinetics and Biopharmaceutics, 1997
- Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticariaAllergy, 1996
- Efficacy and Safety of Mizolastine in Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1996
- The Pharmacology and Use of H1-Receptor-Antagonist DrugsNew England Journal of Medicine, 1994
- In vivo antigen-induced cutaneous mediator release: Simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administrationJournal of Allergy and Clinical Immunology, 1990
- In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in manJournal of Allergy and Clinical Immunology, 1990
- Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionJournal of Allergy and Clinical Immunology, 1989
- Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skinJournal of Allergy and Clinical Immunology, 1988